We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.3B
AUM Growth
-$6.59M
Cap. Flow
+$16.8M
Cap. Flow %
0.73%
Top 10 Hldgs %
40.75%
Holding
312
New
11
Increased
145
Reduced
91
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 11.09%
2 Healthcare 7.74%
3 Financials 4.66%
4 Industrials 4.48%
5 Communication Services 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LHX icon
251
L3Harris
LHX
$51.6B
$271K 0.01%
1,228
+21
+2% +$4.78K
INTU icon
252
Intuit
INTU
$86.5B
$265K 0.01%
491
+31
+7% +$16.7K
HOLX
253
DELISTED
Hologic
HOLX
$262K 0.01%
3,543
AMT icon
254
American Tower
AMT
$80.8B
$261K 0.01%
985
+45
+5% +$12.8K
THG icon
255
Hanover Insurance
THG
$8.1B
$259K 0.01%
2,000
ITA icon
256
iShares US Aerospace & Defense ETF
ITA
$14.2B
$257K 0.01%
2,470
SPYV icon
257
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.1B
$257K 0.01%
6,601
+21
+0.3% +$839
ALBO
258
DELISTED
Albireo Pharma Inc
ALBO
$257K 0.01%
8,242
+821
+11% +$25.4K
MPC icon
259
Marathon Petroleum
MPC
$92.4B
$252K 0.01%
4,076
CALA
260
DELISTED
Calithera Biosciences, Inc
CALA
$251K 0.01%
5,754
+200
+4% +$8.63K
A icon
261
Agilent Technologies
A
$39.1B
$249K 0.01%
1,578
FLG
262
Flagstar Bank National Association
FLG
$5.93B
$249K 0.01%
6,453
+2,679
+71% +$97.2K
SSO icon
263
ProShares Ultra S&P500
SSO
$7.87B
$247K 0.01%
8,232
ILCV icon
264
iShares Morningstar Value ETF
ILCV
$1.32B
$246K 0.01%
3,858
VCSH icon
265
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$245K 0.01%
2,973
CI icon
266
Cigna
CI
$73.7B
$239K 0.01%
1,194
SCHD icon
267
Schwab US Dividend Equity ETF
SCHD
$103B
$239K 0.01%
9,660
+3
+0% +$76
IWS icon
268
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
$236K 0.01%
2,082
+250
+14% +$28.9K
VB icon
269
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$235K 0.01%
1,074
+133
+14% +$29.6K
VO icon
270
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$228K 0.01%
3,856
SCHG icon
271
Schwab US Large-Cap Growth ETF
SCHG
$59.8B
$226K 0.01%
+12,224
New +$233K
ARKG icon
272
ARK Genomic Revolution ETF
ARKG
$1.55B
$225K 0.01%
3,007
-473
-14% -$39.7K
MRNA icon
273
Moderna
MRNA
$21.8B
$220K 0.01%
+572
New +$211K
ABMD
274
DELISTED
Abiomed Inc
ABMD
$219K 0.01%
674
EXC icon
275
Exelon
EXC
$47.2B
$218K 0.01%
6,319
-3,126
-33% -$107K

Similar funds

Grimes & Company's Q3 2021 Portfolio in Review

As of Q3 2021, Grimes & Company held 312 positions worth $2.3B, down 0.29% from $2.3B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Grimes & Company's Q3 2021 filing shows 11 new, 145 increased, 91 reduced and 11 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 586,638 shares worth $22M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $21.3M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

  • Grimes & Company's largest Q3 2021 buy was State Street Financial Select Sector SPDR ETF: 586,638 shares worth $22M.
  • Grimes & Company added most to State Street Blackstone Senior Loan ETF in Q3 2021, an estimated $13.4M increase.
  • Grimes & Company's biggest Q3 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $21.3M.
  • Grimes & Company fully exited State Street Consumer Staples Select Sector SPDR ETF in Q3 2021, selling an estimated $16.6M.
  • Grimes & Company's ten largest holdings make up 41% of its $2.3B portfolio in Q3 2021.
  • Grimes & Company opened 11 new positions and closed 11 in Q3 2021.
  • Grimes & Company's portfolio value fell 0.29% quarter-over-quarter to $2.3B.

Based on Grimes & Company's 13F filing for Q3 2021, filed 8 Nov 2021.